Executive record
Alpha ID: alpha:person:michael-a-white-idyaVersion: public-0As of: 2026-09-30
- Executive
Key Claims
Biography
Has served as Chief Scientific Officer since October 2021, with prior roles as CSO at Biosplice Therapeutics and CSO and Head of Tumor Biology at Pfizer. Previously a Professor of Cell Biology and founding Director of the Cancer Intervention and Prevention Discovery Program at UT Southwestern Medical Center for over 20 years.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Executive career
- Current · dates not publishedChief Scientific Officer · IDEAYA Biosciences, Inc.
- 2026 to end not publishedExecutive title: Chief Scientific Officer · Organization not publishedIDYA DEF 14A executive officers
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
IDYA DEF 14A executive officers
sec filing · Source published: Apr 29, 2026 · Retrieved: May 15, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
- Executive title: Executive title: Chief Scientific Officer · Claim reviewed: May 15, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026
Open source
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 1 claim
- Professional Role: Chief Scientific Officer at IDEAYA Biosciences, Inc. · Claim reviewed: Sep 6, 2026
IDYA executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
- Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
- Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Scientific Officer · Claim reviewed: May 15, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-30
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

